Yaling Hu

Sinovac Biotech ORCID: 0000-0002-6976-459X

1

h-index

1

Publications

1,488

Citations

Publications

1 shown

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang , Gang Zeng , Hongxing Pan +17 more

2020 The Lancet Infectious Diseases 1488 citations

Frequent Co-Authors

Yanjun Zhang

Zhejiang Center for Disease Control and Prevention

Gang Zeng

Sinovac Biotech

Hongxing Pan

Jiangsu Provincial Center for Disease Control and Prevention

Changgui Li

National Institutes for Food and Drug Control

Kai Chu

Jiangsu Provincial Center for Disease Control and Prevention

Weixiao Han

Sinovac Biotech

Researcher Info

h-index: 1
Publications: 1
Citations: 1,488
Institution: Sinovac Biotech

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-6976-459X

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.